Howard Mayer

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

Roy M. Gulick, Jacob Lalezari, James Goodrich et al. · New England Journal of Medicine · 2008 · 735 citations · Full text

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

Gerd Fätkenheuer, Mark Nelson, Adriano Lazzarin et al. · New England Journal of Medicine · 2008 · 359 citations

Pharmacodynamics of Fluoroquinolones against <i>Streptococcus pneumoniae</i> in Patients with Community-Acquired Respiratory Tract Infections

Paul G. Ambrose, Dennis M. Grasela, Thaddeus H. Grasela et al. · Antimicrobial Agents and Chemotherapy · 2001 · 297 citations · Full text

Vitro Susceptibility, S. Pneumoniae, Pharmacotherapy +19

Molecular and Clinical Epidemiology of CXCR4‐Using HIV‐1 in a Large Population of Antiretroviral‐Naive Individuals

Zabrina L. Brumme, James Goodrich, Howard Mayer et al. · The Journal of Infectious Diseases · 2005 · 269 citations · Full text

Maraviroc versus Efavirenz, Both in Combination with Zidovudine‐Lamivudine, for the Treatment of Antiretroviral‐Naive Subjects with CCR5‐Tropic HIV‐1 Infection

David A. Cooper, Jayvant Heera, James Goodrich et al. · The Journal of Infectious Diseases · 2010 · 265 citations